Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label trial investigating the efficacy and safety of abatacept in ankylosing
spondylitis. It is planned to treat 30 patients with ankylosing spondylitis from baseline up
to week 30. Abatacept will be administered intravenously according to the prescription used
in rheumatoid arthritis.